News, a surgical video, and links related to infertility and fertility preservation.
In a world first, a woman has delivered a healthy boy after transplantation of her own ovarian tissue that was cryopreserved during childhood. Reporting on the case in Human Reproduction, Belgian researchers said the outcome “offers reassuring evidence for the feasibility” of cryopreservation of ovarian tissue prior to puberty.
Age 27 when she gave birth, the mother received a diagnosis of sickle cell anemia at age 5. At age 13 years and 11 months, she underwent a right oophorectomy with removal and cryopreservation of 62 fragments of ovarian tissue. The fertility-sparing procedures were approved by her parents in advance of their child’s treatment with chemotherapeutic conditioning followed by hematopoietic stem cell transplantation.
At the time of cryopreservation, the patient had undergone puberty but had not menstruated. When she was age 15 ½, menarche was induced with a third-generation estrogen-progesterone preparation.
At age 25, because the patient wanted to become pregnant, grafting of thawed ovarian tissue was performed. Four segments were grafted on the residual left ovary, six were grafted in the right peritoneal bursa, and five were grafted subcutaneously using a trocar incision. From the time the woman began to menstruate 5 months later, her menstrual cycles were regular. For two years thereafter and with a partner with male infertility, she did not conceive. The pregnancy that resulted in the historic live birth was spontaneous and with a new partner.
Cryopreservation of ovarian tissue is common, the authors said, to preserve fertility in children but their report provides “evidence for the long-term survival of autografts of ovarian tissue cryopreserved before menarche and the efficiency of the procedure to restore fertility.”
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More